An autosomal recessive leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis pigmentosa maps to chromosome 17q24.2-25.3
Tóm tắt
Single-gene disorders related to ischemic stroke seem to be an important cause of stroke in young patients without known risk factors. To identify new genes responsible of such diseases, we studied a consanguineous Moroccan family with three affected individuals displaying hereditary leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis pigmentosa that appears to segregate in autosomal recessive pattern. All family members underwent neurological and radiological examinations. A genome wide search was conducted in this family using the ABI PRISM linkage mapping set version 2.5 from Applied Biosystems. Six candidate genes within the region linked to the disease were screened for mutations by direct sequencing. Evidence of linkage was obtained on chromosome 17q24.2-25.3. Analysis of recombination events and LOD score calculation suggests linkage of the responsible gene in a genetic interval of 11 Mb located between D17S789 and D17S1806 with a maximal multipoint LOD score of 2.90. Sequencing of seven candidate genes in this locus, ATP5H, FDXR, SLC25A19, MCT8, CYGB, KCNJ16 and GRIN2C, identified three missense mutations in the FDXR gene which were also found in a homozygous state in three healthy controls, suggesting that these variants are not disease-causing mutations in the family. A novel locus for leucoencephalopathy with ischemic stroke, dysmorphic syndrome and retinitis pigmentosa has been mapped to chromosome 17q24.2-25.3 in a consanguineous Moroccan family.
Tài liệu tham khảo
Meschia JF: New information on the genetics of stroke. Curr Neurol Neurosci Rep. 2011, 11: 35-41. 10.1007/s11910-010-0155-x.
Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996, 383: 707-710. 10.1038/383707a0.
Tang SC, Jeng JS, Lee MJ, Yip PK: Notch signaling and CADASIL. Acta Neurol Taiwan. 2009, 18: 81-90.
Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schäfer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP: C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet. 2007, 39: 1068-1070. 10.1038/ng2082.
Leibrero A, Martins E, Cruz C, Almeida J, Maciel MJ, Cardoso JC, Lima CA: Marfan syndrome: clinical manifestations, pathophysiology and new outlook on drug therapy. Rev Port Cardiol. 2010, 29: 1021-1036.
Watanabe A, Shimada T: Vascular type of Ehlers-Danlos syndrome. J Nippon Med Sch. 2008, 75: 254-261. 10.1272/jnms.75.254.
Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M, Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O: Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med. 2009, 360: 1729-1739. 10.1056/NEJMoa0801560.
Finger RP, Charbel Issa P, Ladewig MS, Götting C, Szliska C, Scholl HP, Holz FG: Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol. 2009, 54: 272-285. 10.1016/j.survophthal.2008.12.006.
Dichgans M: Genetics of ischaemic stroke. Lancet Neurol. 2007, 6: 149-161. 10.1016/S1474-4422(07)70028-5.
Schiffmann R: Fabry disease. Pharmacol Ther. 2009, 122: 65-77. 10.1016/j.pharmthera.2009.01.003.
Takahachi JC, Miyamoto S: Moyamoya disease: recent progress and outlook. Neurol Med Chir (Tokyo). 2010, 50: 824-832. 10.2176/nmc.50.824.
Herve D, Touraine P, Verloes A, Miskinyte S, Krivosic V, Logeart D, Alili N, Laredo JD, Gaudric A, Houdart E, Metzger JP, Tournier-Lasserve E, Woimant F: A hereditary moyamoya syndrome with multisystemic manifestations. Neurology. 2010, 75: 259-264. 10.1212/WNL.0b013e3181e8ee3f.
Ikeda H, Sasaki T, Yoshimoto T, Arinami T: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999, 64: 533-537. 10.1086/302243.
Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M: Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000, 15: 179-182. 10.1177/088307380001500307.
Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000, 31: 930-935. 10.1161/01.STR.31.4.930.
Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A: Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008, 70: 2357-2363. 10.1212/01.wnl.0000291012.49986.f9.
Gudbjartsson DF, Jonasson K, Frigge ML, Kong A: Allegro, a new computer program for multipoint linkage analysis. Nat Genet. 2000, 25: 12-13. 10.1038/75514.
van der Deure WM, Peeters RP, Visser TJ: Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol. 2010, 44: 1-11. 10.1677/JME-09-0042.
Fordel E, Geuens E, Dewilde S, De Coen W, Moens L: Hypoxia/ischemia and the regulation of neuroglobin and cytoglobin expression. IUBMB Life. 2004, 56: 681-687. 10.1080/15216540500037406.
Gogas KR: Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin Pharmacol. 2006, 6: 68-74. 10.1016/j.coph.2005.11.001.
Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortüm F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tönnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K: Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet. 2010, 42: 1021-1026. 10.1038/ng.677.
Rajakulendran S, Tan SV, Hanna MG: Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome. Pract Neurol. 2010, 10: 227-231. 10.1136/jnnp.2010.217794.
Scholl UI, Choi M, Liu T, Häusler MG, Grimmer J, Tobe SW, Farhi A, Nelson-Williams C, Lifton RP: Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Nat Acad Sci USA. 2009, 106: 5842-5847. 10.1073/pnas.0901749106.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/13/18/prepub